Susquehanna International Group, LLP Eye Point Pharmaceuticals, Inc. Transaction History
Susquehanna International Group, LLP
- $688 Billion
- Q2 2025
A detailed history of Susquehanna International Group, LLP transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 281,115 shares of EYPT stock, worth $3.34 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
281,115
Previous 148,049
89.88%
Holding current value
$3.34 Million
Previous $802,000
229.8%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding EYPT
# of Institutions
160Shares Held
67.1MCall Options Held
214KPut Options Held
994K-
Cormorant Asset Management, LP Boston, MA8.33MShares$99 Million7.9% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.8MShares$80.9 Million2.2% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.8MShares$80.9 Million0.11% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.6MShares$54.7 Million0.09% of portfolio
-
Franklin Resources Inc San Mateo, CA4.3MShares$51.1 Million0.01% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $405M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...